0001309014-11-000277.txt : 20110512 0001309014-11-000277.hdr.sgml : 20110512 20110512090100 ACCESSION NUMBER: 0001309014-11-000277 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110512 FILED AS OF DATE: 20110512 DATE AS OF CHANGE: 20110512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KONINKLIJKE PHILIPS ELECTRONICS NV CENTRAL INDEX KEY: 0000313216 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05146-01 FILM NUMBER: 11833920 BUSINESS ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC BUSINESS PHONE: 31 20 59 77777 MAIL ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS ELECTRONICS N V DATE OF NAME CHANGE: 19930727 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS NV DATE OF NAME CHANGE: 19910903 6-K 1 htm_5812.htm LIVE FILING Koninklijke Philips Electronics N.V. - Form 6-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

May 12, 2011

Koninklijke Philips Electronics N.V.
———————————————————————————————————
(Translation of registrant’s name into English)
 
The Netherlands
———————————————————————————————————
(Jurisdiction of incorporation or organization)
 
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
———————————————————————————————————
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:  [x] Form 20-F    [ ] Form 40-F
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  [ ]
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  [ ]
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:  [ ] Yes    [x] No
 
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):    n/a 
 

This report comprises a copy of the following press release:

- “Philips updates markets on Healthcare sector in meeting with investors and
financial analysts”, dated May 12, 2011.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
    Koninklijke Philips Electronics N.V.
     
Date: May 12, 2011 By: /s/ E.P. Coutinho

  Name:  E.P. Coutinho
  Title: General Secretary
     

EXHIBIT INDEX

Exhibit No.   Description

 
99   Press release
     

EX-99 2 exhibit1.htm EX-99 Exhibit  EX-99

Philips updates markets on Healthcare sector in meeting with investors and financial analysts

May 12, 2011

Boston, Massachusetts, USA – At a meeting with investors and financial analysts today in Boston, USA, Royal Philips Electronics (NYSE: PHG, AEX: PHI) will update the financial market on the developments in the relevant Healthcare markets, and the progress made by the Healthcare sector.

Philips Chief Executive Officer Frans van Houten will comment on the opportunities and near-term actions to drive performance improvements. To underline Philips’ commitment to strengthen local market entrepreneurship, Mr. Van Houten will discuss the recent appointment of a full-time Chief Market Leader, who will report directly to him. After the remarks, Mr. Van Houten and Chief Financial Officer Ron Wirahadiraksa will take part in a question-and-answer session with the investors and analysts present in Boston.

At the event, Healthcare executives including Steve Rusckowski, Chief Executive Officer of Philips Healthcare, will comment on current market views and business priorities. The executives will discuss how the Healthcare sector is executing on its strategy to accelerate growth by leveraging leadership positions and capturing market share growth potential in growth markets.

“Philips Healthcare’s growth and earnings trajectory has been solid, demonstrating the strength in our businesses and geographies,” said Mr. Rusckowski. “Going forward, we will further accelerate growth by driving business-market execution.”

Presentations in Boston, USA will start at 8:30 AM local time or 2:30 PM CET. Please visit this link to listen to the webcast and download the slides that will be used during the day.

For further information, please contact:
Joost Akkermans
Corporate Communications
Tel: +31 20 5977 406
E-mail: joost.akkermans@philips.com

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs about 117,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.